Formulary Monographs [ATAZANAVIR|RITONAVIR, 08180892]
|
|
ATAZANAVIR | RITONAVIR
|
|
|
|
|
|
ANTIRETROVIRALS MISCELLANEOUS
|
|
|
HIV-1 infection in treatment -naïve and treatment-experienced adults and pediatric patients 6 years of age or older.
|
|
|
Rash, abdominal pain, diarrhoea, nausea, unconjugated hyper- bilirubinemia, headache, lactic acidosis.
|
|
|
Adult: Atazanavir 300mg/ ritonavir 100mg once daily with food.
|
|
|
|
|
|
Ritonavir-Although the limited human data do not allow a better assessment of the risk of ritonavir during pregnancy, the animal data suggest that the drug may represent a low risk to the developing fetus.
Atazanavir-Although the limited human data preve |
|
|
Ritonavir-No reports describing the use of ritonavir during lactation have been located. The molecular weight (about 721) is low enough that excretion into breast milk should be expected. The effect on a nursing infant is unknown.
Atazanavir-No reports d |
|
|
|